Zhengye Biotechnology Holding Limited (ZYBT)

ZYBT Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Year	2022	2021
Cash & Equivalents	9.75	6.28
Short-Term Investments	30.68	18.28
Cash & Cash Equivalents	40.43	24.56
Cash Growth	64.58%	-
Receivables	102.9	83.42
Inventory	55.42	43.62
Other Current Assets	15.56	13.34
Total Current Assets	214.31	164.94
Property, Plant & Equipment	275.17	246.34
Goodwill and Intangibles	27.96	20.82
Other Long-Term Assets	2.23	13.17
Total Long-Term Assets	305.37	280.34
Total Assets	519.67	445.28
Accounts Payable	79.28	77.57
Current Debt	54.89	30
Other Current Liabilities	18.06	18.06
Total Current Liabilities	152.23	125.63
Long-Term Debt	9.99	-
Other Long-Term Liabilities	0.59	0.82
Total Long-Term Liabilities	10.58	0.82
Total Liabilities	162.81	126.44
Total Debt	64.88	30
Debt Growth	116.27%	-
Retained Earnings	65.77	42.33
Shareholders' Equity	356.87	318.84
Net Cash / Debt	-24.46	-5.44
Working Capital	62.08	39.32

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).